1.8
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response…
A drug activates its receptor by inducing conformational changes or recruiting effector molecules to generate a cellular response. However, not all drugs activate their target or receptors upon binding.
Drug binding depends on the drug's affinity for the receptor. Even at low concentrations, high-affinity drugs compete with endogenous ligands for maximum receptor occupancy.
A drug's efficacy determines its ability to elicit a cellular response. Drugs are categorized as agonists, partial agonists, or antagonists based on their affinity and efficacy.
An agonist activates the receptor to elicit a maximal response. Agonists can bind to an endogenous ligand binding site or a separate allosteric site to increase a receptor's activity. Even without total occupancy of receptors, the efficacy of an agonist remains nearly 100%.
A partial agonist has intermediate efficacy and can only produce a submaximal response even with 100% receptor occupancy.
Finally, an antagonist competes with the endogenous ligand to bind and inactivate the receptor. So, the antagonist has negligible efficacy and does not produce a response.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between drug affinity and drug efficacy?
Drug affinity is the ability of a drug to bind to its receptor, determining how readily it occupies receptor sites even at low concentrations. Efficacy is the drug's ability to activate the receptor and elicit a cellular response. High-affinity drugs compete effectively with endogenous ligands for receptor occupancy, while efficacy determines whether that binding produces a maximal, submaximal, or negligible response.
Q2: How do agonists activate receptors to produce a cellular response?
Agonists activate receptors by inducing conformational changes or recruiting effector molecules that generate a cellular response. They can bind to the endogenous ligand binding site or a separate allosteric site to increase receptor activity. Agonists have high affinity and nearly 100% efficacy, producing maximal responses even without total receptor occupancy.
Q3: Why do partial agonists produce submaximal responses despite full receptor occupancy?
Partial agonists have intermediate efficacy, meaning they cannot fully activate receptors even when bound to all available receptor sites. Unlike agonists with nearly 100% efficacy, partial agonists are intrinsically limited in their ability to generate a cellular response. This reduced efficacy results in submaximal tissue responses regardless of complete receptor occupancy.
Q4: What mechanism allows antagonists to block drug responses?
Antagonists compete with endogenous ligands and agonists for receptor binding sites, stabilizing the receptor in an inactive state. They have negligible efficacy and do not produce a response themselves. By occupying receptors, antagonists prevent agonists from binding and activating the receptor, effectively blocking the cellular response.
Q5: How do allosteric antagonists differ from pharmacologic antagonists?
Pharmacologic antagonists compete directly with other molecules for the same receptor binding site and stabilize the receptor in an inactive state. Allosteric antagonists bind to separate sites on the receptor and change the affinity and efficacy of agonists without competing for the primary binding site. Both reduce receptor activation but through distinct mechanisms.
Q6: Why is understanding drug-receptor binding essential for predicting drug effects?
Drug-receptor interactions determine whether a drug activates or inactivates its target, directly influencing tissue response. The drug's affinity, efficacy, and binding mechanism—whether at the agonist site or allosteric site—collectively determine its pharmacological effect. Understanding these interactions is critical for predicting how factors affecting drug response will influence therapeutic outcomes.
Q7: What determines whether a drug will be classified as an agonist, partial agonist, or antagonist?
Drug classification depends on two parameters: affinity and efficacy. Agonists have high affinity and high efficacy, producing maximal responses. Partial agonists have high affinity but intermediate efficacy, producing submaximal responses. Antagonists have variable affinity but negligible efficacy, producing no response. These properties determine the drug's functional effect on tissue.